Catalyst
Slingshot members are tracking this event:
FDA Approves Egalet's (EGLT) ARYMO ER C-II for Treatment of Chronic Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EGLT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Arymo Er, C-ii, Abuse-deterrent Properties, Chronic Pain, New Drug Application, Fda
